Navigation Links
AlloSource Joins Alliance for Regenerative Medicine, Medical Device Manufacturers Association
Date:8/9/2011

CENTENNIAL, Colo., Aug. 9, 2011 /PRNewswire/ -- AlloSource, a leading developer, processor and distributor of bone and soft-tissue allografts for use in surgical procedures around the world, today announced two new key affiliations with the Alliance for Regenerative Medicine (ARM) and the Medical Device Manufacturers Association (MDMA).  AlloSource pursued membership with both organizations in order to support medical device and regenerative medicine grassroots efforts with policy makers.

ARM is a nonprofit whose mission is to educate key policy makers about the potential of regenerative medicine and to advocate for favorable public policies to facilitate advances in the field. MDMA is a national trade association providing educational and advocacy assistance to innovative and entrepreneurial medical technology companies.  Both organizations have already made progress in growing the knowledge base of Capitol Hill influencers on the current industry issues that affect their member organizations.

"AlloSource honors the gift of life from donors and their families by safely and respectfully processing donated tissue, and because of this we are dedicated to expanding the medical possibilities of tissue transplantation," Thomas Cycyota, AlloSource President and CEO.  "We look forward to working with the Alliance for Regenerative Medicine and the Medical Device Manufacturers Association to educate regulators on the ways regenerative medicine and medical devices using donated tissue do and will continue to greatly improve the quality of life for millions of patients in need."

AlloSource recently expanded its product offerings with the addition of AlloStem® Stem Cell Bone Growth Substitute, which pioneers the use of mesenchymal stem cells derived from donor adipose tissue for orthopedic applications, helping to stimulate natural bone formation. Through the osteobiologics products they produce, the company has facilitated approximat
'/>"/>

SOURCE AlloSource
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Medical Device Industry Veteran Angela Horacek Joins AlloSource as VP of Operations
2. AlloSource Named Colorados Top Healthcare Company
3. AlloSource and Partners Provide Life-Saving Burn Treatment to Haitian Earthquake Survivors
4. AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float
5. Michael Showalter Joins Prime Therapeutics As Chief Marketing Officer
6. Timothy Cote, MD, MPH, Joins NORD as Chief Medical Officer
7. INTENSA Medical Furniture Joins Attainia
8. Sol J. Barer, Ph.D. Joins InspireMD Board of Directors
9. Genetix Joins Molecular Devices: Combining Businesses to be in a Better Position to Serve Customers
10. Bacterin Joins Russell 3000, Russell Microcap, and Russell Global Indexes
11. Drs. Ben Machielse Joins Omthera Pharmaceuticals, Inc. as Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... CAMBRIDGE, Mass. , Jan. 15, 2014  Zafgen, ... the unmet needs of severely obese patients, today ... of beloranib, a selective inhibitor of methionine aminopeptidase ... a severe form of genetic obesity.  These results ...
(Date:1/14/2014)... Jan. 14, 2014  Luminex Corporation (Nasdaq: LMNX ) ... fourth quarter of 2013 on Monday, February 3, 2014. A ... the close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ... discuss the operating highlights and financial results for the fourth ...
(Date:1/14/2014)... Healthcare Services, Inc. ("DHS"), a portfolio company of GMH Ventures ... Equipment, Inc. ("Progressive") of Clarion, PA ... not disclosed. Progressive is a full service ... sleep, mobility, and respiratory products to customers in the western ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... 7, 2011 In an address to ... John C. Lechleiter, Ph.D., chairman, president and chief executive ... build a new level of trust between the biopharmaceutical ... can harness innovation to help meet growing health care ...
... 2011 Merit Medical Systems, Inc. (NASDAQ: MMSI ... used primarily in cardiology, radiology and endoscopy, announced today that ... quarter ended June 30, 2011, after the close of the ... will hold its investor conference call on the same day ...
Cached Medicine Technology:Lilly CEO Calls for Improved Dialogue in Germany Between Industry and the Government and Health Care System 2Lilly CEO Calls for Improved Dialogue in Germany Between Industry and the Government and Health Care System 3Lilly CEO Calls for Improved Dialogue in Germany Between Industry and the Government and Health Care System 4
(Date:7/10/2014)... one of the top public health concerns in the ... classified as obese as of 2012. As health problems ... taken to Twitter to discuss the problem. , A ... professor at the Brown School at Washington University in ... in tweets to track Twitter conversations about the issue ...
(Date:7/10/2014)... Up to 70% of Parkinson,s disease (PD) ... quality of life. Some patients have disturbed sleep/wake ... asleep, while other patients may be subject to ... extreme, PD patients may exhibit REM-sleep behavior disorder ... re-enactment, even before motor symptoms appear. A review ...
(Date:7/10/2014)... 10, 2014) A research review identifying the clinical ... first step in the process of developing evidence-based guidelines ... new report published by Neurosurgery , ... Surgeons . The journal is published by Lippincott ... Wolters Kluwer Health . , Based on analysis ...
(Date:7/10/2014)... Biomedical Research Institute (IDIBELL) and the Catalan Institute of ... new therapeutic combination to combat resistant sarcomas. The clinical ... stabilize the growth of these tumors have been published ... ., Sarcomas , Sarcomas are a rare type ... It can affect from children to older ages. It ...
(Date:7/9/2014)... WASHINGTON, DC (July 10, 2014) If you think winning ... fun for kids think again: Winning along with other mental ... each of which falls into one of 11 big fun ... that winning is all important when it comes to the ... identify and quantify what goes into this elusive conceptuntil now. ...
Breaking Medicine News(10 mins):Health News:Study looks at how Twitter can be used to address specific health issues 2Health News:Sleep disturbances, common in Parkinson's disease, can be early indicator of disease onset 2Health News:What's a concussion? Review identifies four evidence-based indicators 2Health News:What's a concussion? Review identifies four evidence-based indicators 3Health News:New therapeutic combination to slow resistant sarcomas 2Health News:Being a good sport ranks as the top 'fun' factor in study of youth sports 2Health News:Being a good sport ranks as the top 'fun' factor in study of youth sports 3
... other organizations must intensify efforts to improve the health ... where the lion,s share of deaths occur, says Dr. ... & gynecology. Baker is the lead author on a ... the world,s leading medical experts on women and children,s ...
... study appearing in the journal PLoS ONE, ... mathematical patterns underlying the way individuals unconsciously distribute ... their environment. These patterns appear to meet ... is a scientific law and, if confirmed in ...
... study shows , WEDNESDAY, May 26 (HealthDay News) - A ... is no longer so deadly, thanks to new technologies and ... researchers report. , A study in the May 27 issue ... the effectiveness of older and newer versions of devices aimed ...
... right thing, researcher says , WEDNESDAY, May 26 (HealthDay News) ... open the door for manufacturers and restaurants to add other ... study finds. , A team from Harvard School of Public ... found little cause for alarm. , "We found that in ...
... of Medicine of the National Academies will convene a ... Illinois at Chicago to discuss the rapidly rising rates ... UIC Midwest Conference on Diabetes and Obesity will bring ... Causes, treatment, preventive measures and policy issues will be ...
... analyzing 2.5 million screening mammograms performed on nearly one ... improved over a nine-year period. Results of the study ... Radiology . "To our knowledge, this is ... in a large representative sample of women undergoing screening ...
Cached Medicine News:Health News:Study finds 'law-like' patterns in human preference behavior 2Health News:Study finds 'law-like' patterns in human preference behavior 3Health News:Progress Made Against Once-Fatal Heart Defect 2Health News:Progress Made Against Once-Fatal Heart Defect 3Health News:Healthier Fats Replacing Trans Fats, Study Finds 2Health News:Healthier Fats Replacing Trans Fats, Study Finds 3Health News:UIC to host Institute of Medicine Meeting on diabetes and obesity 2Health News:Detection of breast cancer in screening mammography has improved over time 2
Interphlex Flexible Stablization Rods offer correction of Hammer Toes with a High level of Flexibility while maintaining correct toe length and shape....
The Continuous Wave II Arthroscopy Pump provides pulse-free, continuous fluid inflow for joint distention when used in conjunction with a high flow sheath or separate inflow cannula....
True/Fix Distal Femoral Nail System...
... part in our daily lives. But degenerative ... cause severe handicaps. A decisive consideration in ... to produce a reconstructed joint function that ... possible.,The cementless RM Finger System has proven ...
Medicine Products: